Biohit Oyj (BIOBV.HE) Stock Price

Biohit Oyj Price

OMX·CLOSED
2.17
​
Market closed

Revenue at Biohit Oyj has contracted by 3.6% per year over the past 19 years to 15.70 M EUR. Earnings per share have grown at 5.8% per year over the last 17 years. For Biohit Oyj, the net margin of 17.4% is up versus -16.0% a few years ago. At today's price the dividend yield works out to roughly 33.34%. The consensus 12-month price target for Biohit Oyj is 3.57 EUR, about 64.5% above where the stock trades today. Of 9 analysts, 8 rate the stock a buy — an overall Buy consensus.

Biohit Oyj stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Biohit Oyj business model & stock analysis

Biohit Oyj engages in the development, manufacture, and market of diagnostic tests and analysis systems. The company is headquartered in Helsinki, Etela-Suomen. The firm operates one business segment, named Diagnostics. The Diagnostics segment offers solutions for the early diagnosis and prevention of gastrointestinal diseases. The company provides blood-sample examination based on GastroPanel for the diagnosis of stomach illnesses and associated risks, quick tests for the diagnosis of lactose intolerance and Helicobacter pylori infection in connection with gastroscopy, as well as the ColonView examination for the early detection of fecal occult intestinal bleeding, which indicates a risk of colorectal cancer. The Company’s products are used in hospitals, healthcare centers and research institutions. The company operates primarily in Europe and Asia. Furthermore, the Company is a parent of Biohit Healthcare Ltd, Biohit Healthcare Srl, Oy Finio Ab, and Vantaan Hienomekano Oy, among others.

Frequently asked questions about Biohit Oyj

Analysts currently set an average price target of 3.57 EUR for the Biohit Oyj stock (median: 3.57 EUR), implying +67.6 % versus the latest price. The consensus is based on 9 analyst ratings.

9 analysts currently rate the Biohit Oyj stock: 8 recommend buying, 1 holding and 0 selling. For 2026, analysts expect Biohit Oyj to generate revenue of 16.30 M EUR and earnings per share of 0.14 EUR.

The Biohit Oyj share (BIOBV.HE) is listed on 3 stock exchanges, including: London (0DRP.L).

The expected revenue of Biohit Oyj is 16.30 M EUR. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Biohit Oyj is 2.08 M EUR. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Biohit Oyj is currently 15.88. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Biohit Oyj stock.

The price-to-sales ratio (P/S) of Biohit Oyj is currently 2.02. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Biohit Oyj stock.

The Eulerpool Quality Score for Biohit Oyj is 7/10.

The ISIN of Biohit Oyj is FI0009005482. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Biohit Oyj is BIOBV.HE. The ticker symbol is used to trade Biohit Oyj shares on the stock exchange.

Fair ValueTerminal
1.95 EUR
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Health Care Equipment & Supplies
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Country
Finland
Currency
EUR
Initial public offering
Jun 18, 1999
ISIN
FI0009005482
Cusip
X07214103
Market capitalization
26.52 M EURMicro Cap
52-Week Range
PEG
1.86
P/E ratio
P/Ee 2026
12.76
P/Ee 2027
12.76
P/Ee 2028
12.79
P/Ee 2029
9.94
P/S
P/Se
2.02
EV/EBIT
6.60
P/B Ratio
1.78
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
16.61 %
Dividend
Dividend yield
0.00 %
Est. Dividend Yield
33.34 %
Payout Ratio
0.00 %
Dividend growth Ø5Y
—
Dividend payments per year
1
Dividend paid since
0 years
Dividend not reduced since
0 years
Dividend increased since
0 years
Dividend withholding tax
30.00 %
Last updated Nov 4, 2026, 11:46 AM

Biohit Oyj Peer Group

Biohit Oyj Ticker

HELSINKI · BIOBV.HEHELSINKI · BIOBV.HELONDON · 0DRP.L

Biohit Oyj FIGI

BIOBV:FH · BBG000BXNJ89BIOBV:EO · BBG000JKP042BIOBV:XH · BBG000JKP1P7BIOBV:XC · BBG000JKP220BIOBV:XF · BBG000JKP2G5BIOBV:XE · BBG000JKP4F2BIOBV:XJ · BBG000JKP541BIOBV:XL · BBG000JKP612BIOBV:XG · BBG000JKP6Y6BIOBV:XO · BBG000JKP7B9BIOBV:XS · BBG000JKP970BIOBV:XA · BBG000JKP9R8

All fundamentals and in-depth analysis of Biohit Oyj

Our stock analysis for Biohit Oyj stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Biohit Oyj. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.